We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Parexel 'Not Defensive' Over TeGenero Trial
Parexel 'Not Defensive' Over TeGenero Trial
June 27, 2007
The contract research organization Parexel is “not defensive” over its part in a clinical trial it conducted in the UK last year in which six healthy volunteers became critically ill within hours of taking the first dose of the investigational drug, Chairman and CEO Josef von Rickenbach said.